Mediclinic International plc 2018 Capital Markets Day (8157S)
28 June 2018 - 4:00PM
UK Regulatory
TIDMMDC
RNS Number : 8157S
Mediclinic International plc
28 June 2018
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", the "Company" or the "Group")
28 June 2018
2018 Capital Markets Day
Mediclinic International plc, the international private
healthcare services group, will today host a Capital Markets Day
event and site visit for analysts and investors in Zurich,
Switzerland. No new material information will be provided during
the event and guidance remains unchanged with trading in line with
expectations.
The event will be available via a live webcast at
08:00BST/09:00CEST, details of which can be found below.
The event will include presentations from the Group's CEO and
CFO in addition to operational reviews from the divisional CEO's of
Hirslanden, Mediclinic Southern Africa and Mediclinic Middle
East.
The key theme for the day is Mediclinic's tailored approach to
value creation focusing on:
-- Our diversified international presence and unified focus
-- Strong healthcare market potential
-- Our unique approach to creating value putting patients at the core of our business
-- Our focus on international growth opportunities
-- Our management skills and expertise
-- Financial discipline across the Group
`
Webcast details
A live webcast of today's presentations along with the agenda
and supporting material can be accessed via the Group's Investor
Relations website. Please register for the event, which starts at
08:00 BST/09:00 CEST, via the following link:
https://edge.media-server.com/m6/p/q3ui9j2u
A replay facility will be available on the website from Friday
29 June 2018.
About Mediclinic International plc
Mediclinic is an international private healthcare services
group, established in South Africa in 1983, with current operating
divisions in Southern Africa (South Africa and Namibia),
Switzerland and the United Arab Emirates. Its core purpose is to
enhance the quality of life of patients by providing acute care,
specialist-orientated, multi-disciplinary healthcare services.
Mediclinic also holds a 29.9% interest in Spire Healthcare Group
plc, an LSE-listed and UK-based private healthcare group.
As at the date of this announcement, Mediclinic comprises 75
hospitals and 28 outpatient clinics. Hirslanden operates 17 private
hospitals and 4 clinics in Switzerland with more than 1 800
inpatient beds; Mediclinic Southern Africa operates 49 hospitals
and 2 day clinics throughout South Africa and 3 hospitals in
Namibia with more than 8 100 inpatient beds in total; and
Mediclinic Middle East operates 6 hospitals and 22 clinics with
more than 700 inpatient beds in the United Arab Emirates.
Mediclinic has a primary listing on the Main Market of the LSE
in the United Kingdom, with secondary listings on the JSE in South
Africa and the NSX in Namibia.
For further information, please contact:
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott - UK
+44 (0)20 3727 1000
Sherryn Schooling - South Africa
+27 (0)21 487 9000
Registered address: 6th Floor, 65 Gresham Street, London, EC2V
7NQ, United Kingdom
Website: www.mediclinic.com
Corporate brokers: Morgan Stanley & Co International plc and
UBS Investment Bank
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank
Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCLLFIRRRIDFIT
(END) Dow Jones Newswires
June 28, 2018 02:00 ET (06:00 GMT)
Mediclinic (LSE:MDC)
Historical Stock Chart
From Apr 2024 to May 2024
Mediclinic (LSE:MDC)
Historical Stock Chart
From May 2023 to May 2024